Albuterol sulfate and Sinus polyp - a phase IV clinical study of FDA data

Summary:

Sinus polyp is reported as a side effect among people who take Albuterol sulfate (albuterol sulfate), especially for people who are male, 60+ old, also take Symbicort, and have Cystic fibrosis.

The phase IV clinical study analyzes which people have Sinus polyp when taking Albuterol sulfate. It is created by eHealthMe based on reports of 76,282 people who have side effects when taking Albuterol sulfate from the FDA, and is updated regularly.

What is Albuterol sulfate?

Albuterol sulfate has active ingredients of albuterol sulfate. It is often used in asthma. eHealthMe is studying from 77,268 Albuterol sulfate users. Check the latest studies of Albuterol sulfate.

What is Sinus polyp?

Sinus polyp (abnormal tissue growths that grow inside the nasal passages and sinuses) is found to be associated with 205 drugs and 213 conditions by eHealthMe. Check the latest studies of Sinus polyp.

On Jul, 22, 2026

76,282 people reported to have side effects when taking Albuterol sulfate.
Among them, 21 people (0.03%) have Sinus polyp.

Could Albuterol sulfate cause Sinus polyp?

Among these 21 people:

What is the gender of people who have Sinus polyp when taking Albuterol sulfate? *

female: 31.58 %
male: 68.42 %

What is the age of people who have Sinus polyp when taking Albuterol sulfate? *

What are other drugs people take besides Albuterol sulfate? *

What are other side effects people have besides Sinus polyp? *

Therapeutic Response Decreased (less preventive response): 7 people, 33.33%
Sinusitis (inflammation of sinus): 7 people, 33.33%
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung): 7 people, 33.33%
Viral Infection: 4 people, 19.05%
Headache (pain in head): 4 people, 19.05%
Arthropathy: 4 people, 19.05%
Cataract (clouding of the lens inside the eye): 4 people, 19.05%
Fall: 4 people, 19.05%
Full Blood Count Abnormal: 4 people, 19.05%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 14.29%

What are the existing conditions these people have? *

Cystic Fibrosis (disease of the secretary glands): 4 people, 19.05%
Immunodeficiency Common Variable: 3 people, 14.29%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 4.76%
Pharyngitis (inflammation of the pharynx, causing a sore throat): 1 person, 4.76%
Nasopharyngitis (inflammation of the nasopharynx): 1 person, 4.76%
Nasal Polyps (masses that develop in the lining of the nose): 1 person, 4.76%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 4.76%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.76%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Albuterol sulfate and have Sinus polyp?

- Check whether Sinus polyp is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Albuterol sulfate:

Albuterol sulfate (77,268 reports)

Sinus polyp treatments and more:

Sinus polyp (1,381 reports)

Browse all side effects of Albuterol sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinus polyp:

Sinus polyp (205 drugs)

Browse all the conditions that are associated with Sinus polyp:

Sinus polyp (213 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate (the active ingredients of Albuterol sulfate) and Albuterol sulfate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.